Plasmocitoma testicular bilateral secundario. Aportación de un caso y revisión de la literatura / Secondary bilateral testicular plamacytoma. Case report and review of the literature

El plasmocitoma testicular es una neoplasia de células plasmáticas muy poco frecuente. Generalmente se trata de un hallazgo de autopsia carente de expresión clínica, aunque en algunas ocasiones puede constituir una manifestación de un mieloma múltiple y más excepcionalmente ser su única localización. La afectación bilateral es extremadamente infrecuente. Presentamos el caso de un varón de 58 años con mieloma múltiple en remisión que acude a consulta de urología por aumento progresivo del tamaño testicular bilateral. Tras realización de ecografía y PAAF testicular se diagnostica un plasmocitoma testicular bilateral. El tratamiento incluye cirugía (orquiectomía), radio y quimioterapia. El pronóstico de los pacientes depende de si se trata de un caso de plasmocitoma testicular solitario o con mieloma múltiple asociado (AU)

Testicular plasmacytoma is a very unfrequent plasma cells neoplasm. It is usually an incidental autopsy finding devoid of clinical expression, but it presents sometimes as part of a multiple myeloma and is exceptionally its only location. Bilateral involvement is extremely unfrequent. We report the case of a 58 years old man diagnosed with multiple myeloma in complete remission who complains about progressive enlargement of both testicles. After ultrasonography and PAAF, bilateral testicular plasmacytoma is diagnosed. Treatment includes surgery (orchiectomy), radiotherapy and chemotherapy. Prognostic is worse when multiplemyeloma is associated (AU)

[Inflammatory myofibroblastic tumor. Case report]. / Tumor miofibroblástico inflamatorio vesical. Aportación de un nuevo caso.

OBJECTIVE: To report one case of myofibroblastic bladder tumor. METHODS/RESULTS: We report the case of a 30-year-old woman with recurrent urinary tract infections and incidental finding of a bladder mass after abdominal ultrasound. After TUR, inflammatory myofibroblastic tumor of the bladder was diagnosed. CONCLUSION: Myofibroblastic tumor (also known as inflammatory pseudotumor or pseudosarcoma) is a benign tumor with mesenchymal origin. Bladder location is very uncommon. It must not be misdiagnosed as a malignant neoplasm. Optimal treatment when arising in the bladder is TUR, with excellent long-term prognosis.

Tumor miofibroblástico inflamatorio vesical. Aportación de un nuevo caso / Inflammatory myofibroblastic tumor. Case report

Objetivo: Presentar un nuevo caso de tumor miofibroblástico vesical. Método/Resultados: Mujer de 30 años con ITU de repetición y hallazgo incidental de masa vesical en ecografía abdominal. Tras realización de RTU vesical se diagnostica tumor miofibroblástico inflamatorio de vejiga. Conclusión: El tumor miofibroblástico, (también denominado pseudotumor inflamatorio o pseudosarcoma) es un tumor benigno de origen mesenquimal cuya localización vesical es muy poco común, y que no debe ser confundido con una neoplasia maligna. En caso de presentación vesical el tratamiento consiste en resección transuretral, con buen pronóstico a largo plazo (AU)

Objective: To report one case of myofibroblastic bladder tumor. Methods/Results: We report the case of a 30-year-old woman with recurrent urinary tract infections and incidental finding of a bladder mass after abdominal ultrasound. After TUR, inflammatory myofibroblastic tumor of the bladder was diagnosed. Conclusion: Myofibroblastic tumor (also known as inflammatory pseudotumor or pseudosarcoma) is a benign tumor with mesenchymal origin. Bladder location is very uncommon. It must not be misdiagnosed as a malignant neoplasm. Optimal treatment when arising in the bladder is TUR, with excellent long-term prognosis (AU)

[Secondary bilateral testicular plasmacytoma. Case report and review of the literature]. / Plasmocitoma testicular bilateral secundario. Aportación de un caso y revisión de la literatura.

Testicular plasmacytoma is a very unfrequent plasma cells neoplasm. It is usually an incidental autopsy finding devoid of clinical expression, but it presents sometimes as part of a multiple myeloma and is exceptionally its only location. Bilateral involvement is extremely unfrequent. We report the case of a 58-years-old man diagnosed with multiple myeloma in complete remission who complains about progressive enlargement of both testicles. After ultrasonography and PAAF, bilateral testicular plasmacytoma is diagnosed. Treatment includes surgery (orchiectomy), radiotherapy and chemotherapy. Prognostic is worse when multiple myeloma is associated.

Tumor fibroso solitario inguinal maligno. Aportación de un caso / Solitary malignant fibrous inguinal tumor. Case report

OBJETIVO: El Tumor Fibroso Solitario (TFS) es una neoplasia poco frecuente que fue descrita por primera vez en la pleura, pero puede aparecer en diferentes localizaciones. Su presencia en la zona inguinal es extremadamente rara. MÉTODO/RESULTADOS: Presentamos el caso de un varón de 74 años con masa inguinoescrotal derecha de 50 años de evolución. Tras extirpación quirúrgica de la misma es diagnosticado de tumor fibroso solitario. CONCLUSIONES: La inmensa mayoría de los tumores fibrosos solitarios se comportan de manera benigna. Un pequeño porcentaje se comporta de modo más agresivo, con recurrencia local y metástasis. Su tratamiento es eminentemente quirúrgico, pero después debemos realizar seguimiento a largo plazo en todos los casos (AU)

OBJECTIVE: Solitary fibrous tumours (SFTs) are rare neoplasias that were first reported in pleura, but can occur in different sites. Inguinal location is extremely rare. METHODS/RESULTS: We report one case of a 74 year old man with a right inguinoscrotal mass with 50 years of evolution. After surgical extirpation, solitary fibrous tumour was diagnosed. CONCLUSIONS: The vast majority of solitary fibrous tumours (SFTs) have a benign course. Only a few cases have aggressive behaviour, with local recurrence and metastasis. Treatment is surgical, but we must do a long-term follow up in all cases (AU)

[Solitary malignant fibrous inguinal tumor. Case report]. / Tumor fibroso solitario inguinal maligno. Aportación de un caso.

OBJECTIVE: Solitary fibrous tumours (SFTs) are rare neoplasias that were first reported in pleura, but can occur in different sites. Inguinal location is extremely rare. METHODS/RESULTS: We report one case of a 74 year old man with a right inguinoscrotal mass with 50 years of evolution. After surgical extirpation, solitary fibrous tumour was diagnosed. CONCLUSIONS: The vast majority of solitary fibrous tumours (SFTs) have a benign course. Only a few cases have aggressive behaviour, with local recurrence and metastasis. Treatment is surgical, but we must do a long-term follow up in all cases.

Forma de presentación seudotumoral de tuberculosis urogenital: caso clínico / Urogenital tuberculosis. Starting with haematuria and a bladder mass

Describimos un caso de tuberculosis urogenital que debutó clínicamente con hematuria y una tumoración vesical visible en la cistoscopia. Las imágenes radiológicas del conjunto del aparato urinario permitieron sospechar desde un principio el diagnóstico de tuberculosis, pero la naturaleza de la presentación clínica obligó a descartar una neoplasia urotelial mediante el análisis histopatológico de la tumoración

We describe here in a case of genitourinary tuberculosis presenting with a haematuria and a bladder tubercle. Thouh imaging studies made genitourinary tuberculosis diagnostic feasible, the clinical presentation made runing out malignancy mandatory. Bladder tubercle was endoscopicary removed and histopathological analysis performed

[Urogenital tuberculosis. Starting with haematuria and a bladder mass]. / Forma de presentación seudotumoral de tuberculosis urogenital: caso clínico.

We describe here in a case of genitourinary tuberculosis presenting with a haematuria and a bladder tubercle. Though imaging studies made genitourinary tuberculosis diagnostic feasible, the clinical presentation made runing out malignancy mandatory. Bladder tubercle was endoscopicary removed and histopathological analysis performed.

Amiloidosis localizada de vesículas seminales / Symptomatic localized amyloidosis of the seminal vesicles

La amiloidosis de las vesículas seminales es un hallazgo frecuente en las autopsias, aumentando su incidencia en los individuos de más edad. A pesar de su frecuencia es muy raro que sea sintomática. Presentamos un caso de amiloidosis localizada en las vesículas seminales, sintomático, con hemospermia y dolor suprapúbico, que se diagnosticó mediante biopsias transrectales ecodirigidas. Su presencia obliga a descartar una amiloidosis sistémica. El aumento del tamaño de la vesícula seminal por el depósito de amiloide puede confundirse con una infiltración neoplásica (AU)

Amyloidosis of the seminal vesicles is a common finding in autopsies, with increased incidence in older population. It is usually asymptomatic. We report a case of symptomatic localized amyloidosis of the seminal vesicles, with hemospermia and suprapubic pain. Diagnosis was achieved through ultrasound-guided transrectal biopsy. Systemic amyloidosis must be ruled out through proper evaluation. Seminal vesicle enlargement secondary to amyloid deposit may be misdiagnosed as carcinomatous invasion (AU)

[Localized amyloidosis of the seminal vesicles]. / Amiloidosis localizada de vesículas seminales.

Amyloidosis of the seminal vesicles is a common finding in autopsies, with increased incidence in older population. It is usually asymptomatic. We report a case of symptomatic localized amyloidosis of the seminal vesicles, with hemospermia and suprapubic pain. Diagnosis was achieved through ultrasound-guided transrectal biopsy. Systemic amyloidosis must be ruled out through proper evaluation. Seminal vesicle enlargement secondary to amyloid deposit may be misdiagnosed as carcinomatous invasion.

[Bilateral obstructive uropathy secondary to inguinoscrotal bladder hernia]. / Uropatía obstructiva bilateral secundaria a hernia vesical inguinoescrotal.

Bladder hernia is present in an important number of cases of inguinal hernias. Massive inguinoscrotal bladder hernias are rarer. The association of massive bladder hernia and bilateral ureterohydronephrosis is not often found. According to our knowledge, there have been only seven cases documented in the last ten years. Therefore, we will present a case of renal failure secondary to inguinoscrotal bladder hernia with bilateral obstructive uropathy. Once we have analyzed a clinical case, we will give the diagnosis and treatment for those hernias.

Uropatía obstructiva bilateral secundaria a hernia vesical inguinoescrotal / Bilateral obstructive uropathy secondary to inguinoscrotal bladder hernia

La hernia vesical está presente en un número importante de casos de hernias inguinales. Las hernias vesicales inguinoescrotales masivas son más raras. La asociación de hernia vesical masiva y ureterohidronefrosis bilateral es muy infrecuente, habiéndose documentado hasta la fecha siete casos en la literatura de los últimos diez años, según nuestro conocimiento. Presentamos un nuevo caso de fracaso renal secundario a hernia vesical inguinoescrotal con uropatía obstructiva bilateral, analizando cuadro clínico, pruebas diagnósticas y tratamiento de dichas hernias (AU)

[Early diagnosis of prostate cancer in patients with prostate symptoms by DRE, PSA, TRU and DPSA]. / Diagnóstico precoz del cáncer de próstata en pacientes con sintomatología prostática mediante TR, PSA, ECOTR y DPSA.

Presentation of our experience in the early diagnosis of prostate cancer in patients with signs and symptoms of prostatism. Over a one year period (96-97), 316 patients underwent biopsy based on clearly defined criteria according to the diagnostic algorithm used in our centre: suspicious DRE and/or PSA > or = 10 ng/mL, and in patients with PSA between 4 and 10 ng/mL in the presence of suspicious TRU or when DPSA was > or = 0.15. The ratio of the 136 (43%) prostate cancer diagnosed relative to biopsy +/- was 1:1.32. It is concluded that early diagnosis in a selected population is useful and shows good diagnostic yield. The diagnostic algorithm used is more than acceptable with 43% positive biopsies and a good ratio between biopsy +/-. With a cutoff of 0.15 DPSA is a good method to improve PSA significance in patients in the difficult PSA range of 4 to 10 ng/mL.

[Left supraclavicular adenopathy with a neuroendocrine pattern of unknown cause: prostatic carcinoma metastasis]. / Adenopatía supraclavicular izquierda con patrón neuroendocrino de causa desconocida: metástasis por carcinoma de próstata.

Contribution of a case report of a male patient presenting with single left supraclavicular adenopathy of initially unknown origin and histologic pattern of neuroendocrine nature, finally traced to the prostate. It is believed that in any male over 45 diagnosed with carcinoma of unknown origin in the supradiaphragm lymph nodes, prostate carcinoma metastasis should also be ruled out using PSA immunostaining and by measuring serum PSA, serum alkaline phosphatase and DRE.

[Bladder tumor in pregnancy]. / Tumor vesical durante el embarazo.

Diagnosis of tumours during pregnancy is quite unusual, considering the low frequency of neoplasias in this period (1/1000 pregnancies) as well as the low incidence of bladder cancer in patients under 30, which makes the coincidence of both phenomena quite uncommon. The paper contributes the case of a 28-year old female diagnosed with bladder cancer during her pregnancy.

[Report of a new case of small-cell carcinoma of the bladder and review of the literature]. / Aportación de un nuevo caso de carcinoma de células pequeñas de localización vesical y revisión de la literatura.

We report a case of small cell carcinoma of the urinary bladder in 71-year-old male patient. Oat cell of the urinary bladder is extremely uncommon, and up to date only 135 cases have been reported in word literature. Histologic, microscopic, and immunohistochemical characteristics are similar to oat cell carcinoma of the lung and other extrapulmonary oat cell carcinomas. We conclude this report with immunohistochemical study with PGP 9.5, neuron-specific enolase a synaptophisine.

[Four new cases of urothelial inverted papilloma]. / Cuatro nuevos casos de papiloma invertido urotelial.

Urothelial inverted papilloma account for 2.2% of all urothelial tumours. The preferred location is the bladder; they occur singly and are generally benign, although the majority of authors agrees in treating this entity as a tumour of low aggressiveness. The report contributes four cases of inverted papilloma, three in male patients and the fourth in a female. One was located in the renal pelvis. A revision is made of the etiology, clinical signs and symptoms, diagnosis and treatment, as well as their relationship to surface carcinoma, as it occurs asynchronously in one of the cases described.

[Role of autotransfusion of pre-stored blood in benign prostate hyperplasia. Our experience]. / Papel de la autotransfusión predepósito en la cirugía de la H.B.P. Nuestra experiencia.

The essence of self-transfusion is the extraction of a patient's own blood for subsequent infusion to the same patient. The practice of this strategy has become particularly important from the moment the likelihood of AIDS virus transmission through transfusion with homologous blood products became known. This article presents our experience in both open and endoscopic BPH surgery over the period ranging from January 93 to December 94, and analyzes the health care and socioeconomic aspects of that experience.

[Calmette-Guerin bacillus in the prophylaxis of superficial bladder tumors. Our experience and our doubts]. / Bacilo de Calmette-Guerin en la profilaxis de los tumores superficiales de vejiga. Nuestra experiencia y nuestras dudas.

OBJECTIVE: This study was conducted to determine the efficacy of our BCG dose and schedule for prophylactic therapy in superficial bladder tumors. METHODS: Following complete TUR, 81 mg intravesical BCG were administered weekly for six weeks and for nightly another six times. The patients were evaluated every three months by cytology, cystoscopy and routine analysis. RESULTS: 21/25 patients completed the treatment. At 15.5 months median follow-up, 18/21 (85.7%) were disease-free, 2/21 (9.5%) had recurrence and 1/21 (4.7%) showed disease progression. CONCLUSIONS: BCG is the most effective prophylactic therapy for superficial bladder tumors currently available. The ideal dose, treatment schedule and its mechanism of action are as yet unknown.